Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?

Hana Malíková1, Eva Koubská1, J. Weichet1, Jan Klener2, Aaron Rulseh1, Roman Liščák3, Zdeněk Vojtěch4
1Department of Radiology, Na Homolce Hospital, Roentgenova 2, Prague, 15000, Czech Republic
2Department of Neurosurgery, Na Homolce Hospital, Roentgenova 2, Prague, 15000, Czech Republic
3Department of Stereotactic and Radiation Neurosurgery, Na Homolce Hospital, Roentgenova 2, Prague, 15000, Czech Republic
4Department of Neurology, Na Homolce Hospital, Roentgenova 2, Prague, 15000, Czech Republic

Tóm tắt

Từ khóa


Tài liệu tham khảo

Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O'Rourke DM, Judy KD, Poptani H, Melhem ER. Intraaxial brain masses: MR imaging-based diagnostic strategy–initial experience. Radiology. 2007;243(2):539–50.

van der Sanden GA, Schouten LJ, van Dijck JA, van Andel JP, van der Maazen RW, Coebergh JW, Working Group of Specialists in Neuro-Oncology in the Southern and Eastern Netherlands. Primary central system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer. 2002;94(5):1547–56.

Da Silva AN, Lopez MB, Schiff D. Rare pathological variants and presentations of primary central nervous system lymphomas. Neurosurg Focus. 2006;21(5), E7.

Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med. 2008;132(11):1830–4.

Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol. 1999;43(3):199–201.

Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, Kaplan RS, O'Neill BP. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer. 2002;95(7):1504–10.

Hoffman S, Propp JM, McCarthy BJ. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol. 2006;8(1):27–37.

Partovi S, Karimi S, Lyo JK, Esmaeili A, Tan J, DeAngelis LM. Multimodality imaging of primary CNS lymphoma in immunocompetent patients. Br J Radiol. 2014;87(1036):20130684.

Batchelor T, Loeffler JS. Primary CNS lymphoma. J Clin Oncol. 2006;24(8):1281–8.

Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K, Delattre J-Y. Primary brain tumours in adults. Lancet. 2012;379(9830):1984–96.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–96.

Giese A, Westphal M. Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol. 2001;127(4):217–25.

Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M. Diffusion-weighted MR Imaging of Intracerebral Masses: Comparison with Conventional MR Imaging and Histologic Findings. AJNR. 2001;22(5):969–76.

Weber MA, Zoubaa S, Schlieter M, Jüttler E, Huttner HB, Geletneky K, Ittrich C, Lichy MP, Kroll A, Debus J, Giesel FL, Hartmann M, Essig M. Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology. 2006;66(12):1899–906.

Kickingereder P, Sahm F, Wiestler B, Roethke M, Heiland S, Schlemmer HP, Wick W, von Deimling A, Bendszus M, Radbruch A. Evaluation of microvascular permeability with dynamic contrast-enhanced MRI for the differentiation of primary CNS lymphoma and glioblastoma: radiologic-pathologic correlation. AJNR. 2014;35(8):1503–8.

Ahn SJ, Shin HJ, Chang J-H, Lee S-K. Differentiation between Primary Cerebral Lymphoma and Glioblastoma Using the Apparent Diffusion Coefficient: Comparison of Three Different ROI Methods. PLoS One. 2014;9(11), e112948.

Osborn AG, Salzman KL, Jhaveri MD, editors. Diagnostic Imaging Brain. 3rd ed. Philadelphia: Elsevier; 2016.

Haldorsen IS, Kråkenes J, Krossness BK, Mella O, Espeland A. CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR. 2009;30(4):744–51.

Lenarz M, Durisin M, Becker H, Lenarz T, Nejadkazem M. Primary Central Nervous System Lymphoma Presenting as Bilateral Tumors of the Internal Auditory Canal. Skull Base. 2007;17(6):409–12.

Wang ZT, Su HH, Hou Y, Chu ST, Lai PH, Tseng HH, Lin SJ, Chou YW. Diffuse Large B-cell Lymphoma of the Cerebellopontine Angle in a Patient with Sudden Hearing Loss and Facial Palsy. J Chin Med Assoc. 2007;70(7):294–7.

Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR. 2011;32(6):984–92.

Senocak E, Oguz KK, Ozgen B, Mut M, Ayhan S, Berker M, Ozdemir P, Cila A. Parenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphoma. Eur J Radiol. 2011;79(2):288–94.

Mansour A, Qandeel M, Abdel-Razeq H, Abu Ali HA. MR imaging features of intracranial primary CNS lymphoma in immune competent patients. Cancer Imaging. 2014;14(1):22.

Yamasaki F, Takayasu T, Nosaka R, Amatya VJ, Doskaliyev A, Akiyama Y, Tominaga A, Takeshima Y, Sugiyama K, Kurisu K. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma. J Neurosurg. 2015;122(6):1370–4.

Toh CH, Castillo M, Wong AM, Wei KC, Ng SH, Wan YL. Primary Cerebral Lymphoma and Glioblastoma Multiforme: Differences in Diffusion Characteristics Evaluated with Diffusion Tensor Imaging. AJNR. 2008;29:471–5.

Malikova H, Liscak R, Latnerova I, Guseynova K, Syrucek M, Pytlik R. Complications of MRI-guided stereotactic biopsy of brain lymphoma. Neuro Endocrinol Lett. 2014;35(7):613–8.